General Information
Version
8.6
Revision date
2024-05-28
Product name
Cellvento 4CHO-X COMP Expansion Medium
REACH No
This
1.2.1 Relevant identified uses
Pharmaceutical production
Emergency telephone
+56 2 2581 4934, +56 2 2 2473600, +56 2 2 6353800
Icons in SDS
Company Information
company name
Merck S.A
e-mail address of the competent person responsible for the Safety Data Sheet
atencionclientes@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Eye irritation, (Category 2) H319 Causes serious eye irritation
2.2 Label elements
Labelling
Signal word
Warning Warning
Hazard statements
H319 Causes serious eye irritation. none
Precautionary statements
P264 Wash skin thoroughly after handling. P280 Wear eye protection/ face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 If eye irritation persists: Get medical advice/ attention. none
Supplemental label elements
none EUH208 none
Contains
Pyruvic acid sodium salt. May produce an allergic reaction. Reduced Labeling (<= 125 ml)
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
